{"": [90, 98, 0, 99, 1230, 0], "Introduction": [1231, 6517, 0], "DC- and L-SIGN bind to SARS-CoV-2\u00a0S protein via glycans but cannot directly support SARS-CoV-2 proliferation": [6527, 9342, 0], "DC- and L-SIGN enhance ACE2-mediated SARS-CoV-2 infection (cis-infection) and promotes virus transfer to permissive ACE2+ cells (trans-infection)": [9343, 12450, 0], "SARS-CoV-2\u00a0S protein glycosylation under host epigenetic control and high-mannose (Man5GlcNAc2) glycosylation N1098 site of S protein contributes to enhanced viral binding to L-SIGN receptor and facilitates viral infection": [12451, 20676, 0], "Results": [6518, 20676, 1], "Limitations of the study": [23959, 25102, 0], "Discussion": [20677, 25102, 1], "Key resources table": [25117, 25144, 0], "Lead contact": [25168, 25344, 0], "Materials availability": [25345, 25418, 0], "Resource availability": [25145, 25418, 1], "Cell lines": [25459, 27280, 0], "SARS-CoV-2 viruses": [27281, 29229, 0], "Experimental model and subject details": [25419, 29229, 1], "Affinity measurement by microscale thermophoresis assay": [29246, 30198, 0], "ELISA assay": [30199, 32301, 0], "Viral load and viral titer": [32302, 34469, 0], "Trans-infection and cis-infection assay": [34470, 35474, 0], "Immunofluorescence": [35475, 36426, 0], "Western blotting": [36427, 37047, 0], "Sample and material preparations for LC-MS/MS": [37048, 38072, 0], "Protein digestion": [38073, 40589, 0], "Nano LC-MS/MS analysis": [40590, 41911, 0], "MS Data Analysis": [41912, 43133, 0], "Model building of S trimer": [43134, 43524, 0], "Method details": [29230, 43524, 1], "Quantification and statistical analysis": [43525, 43798, 0], "STAR\u2605Methods": [25103, 43798, 1]}